Scholarlink

Purpose <p>Atopic dermatitis (AD) is a chronic inflammatory skin disease that significantly compromises patients’ quality of life (QoL). The management of AD often focuses on objective clinical measures, overlooking its broader psychosocial and occupational impacts. This article explores how shared decision-making and the treat-to-target strategy can enhance patient-centered care in AD.</p> Recent Findings <p>Recent studies emphasize the importance of addressing not only cutaneous symptoms but also extra-cutaneous comorbidities and psychological challenges in AD. Shared decision-making and treat-to-target, proven effective in managing other chronic diseases, are emerging as valuable strategies for AD treatment. These approaches can enhance treatment adherence, improve patient satisfaction, and ultimately improve overall outcomes.</p> Summary <p>This article explores the potential of integrating shared decision-making and the treat-to-target strategy into AD management. By incorporating these patient-centered approaches, alongside a comprehensive evaluation of disease domains, clinicians can better tailor treatments to individual needs, reduce disease burden, and avoid unnecessary or suboptimal therapies. In addition, a brief overview of available treatment options is provided, offering practical insights for the implementation of these strategies in clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Setting Patient-Centered Treatment Goals in Atopic Dermatitis: Shared Decision and A Treat-to-target Strategy

  • 期刊论文

  • 发表日期：

    2025年2月28日

查看全文
  • Toke Touborg,
  • Anne Sofie Frølunde,
  • Frederikke Seeberg,
  • Mette Deleuran,
  • Christian Vestergaard

摘要

Purpose

Atopic dermatitis (AD) is a chronic inflammatory skin disease that significantly compromises patients’ quality of life (QoL). The management of AD often focuses on objective clinical measures, overlooking its broader psychosocial and occupational impacts. This article explores how shared decision-making and the treat-to-target strategy can enhance patient-centered care in AD.

Recent Findings

Recent studies emphasize the importance of addressing not only cutaneous symptoms but also extra-cutaneous comorbidities and psychological challenges in AD. Shared decision-making and treat-to-target, proven effective in managing other chronic diseases, are emerging as valuable strategies for AD treatment. These approaches can enhance treatment adherence, improve patient satisfaction, and ultimately improve overall outcomes.

Summary

This article explores the potential of integrating shared decision-making and the treat-to-target strategy into AD management. By incorporating these patient-centered approaches, alongside a comprehensive evaluation of disease domains, clinicians can better tailor treatments to individual needs, reduce disease burden, and avoid unnecessary or suboptimal therapies. In addition, a brief overview of available treatment options is provided, offering practical insights for the implementation of these strategies in clinical practice.